or Try an Advanced Search...

    Technical Analysis for APVO - Aptevo Therapeutics Inc.

    Grade Last Price % Change Price Change
    C 0.29 16.05% 0.04
    APVO closed up 16.05 percent on Wednesday, November 20, 2024, on 1.51 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Up
    Historical APVO trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Spinning Top Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 50 DMA Bullish 16.05%
    Older End-of-Day Signals for APVO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 17 hours ago
    20 DMA Support about 17 hours ago
    10 DMA Support about 17 hours ago
    50 DMA Support about 17 hours ago
    Rose Above Previous Day's High about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    APVO Chart by TradingView
    Basic chart:

    Profile

    Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Hematology

    Is APVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
    Oct 29 Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Sep 18 Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 17 Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Sep 17 Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
    Sep 16 Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
    Sep 13 Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
    Aug 30 Aptevo Therapeutics files to sell 13.51M shares of common stock
    Aug 8 Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
    See more APVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.8
    52 Week Low 0.138
    Average Volume 8,474,483
    200-Day Moving Average 1.55
    50-Day Moving Average 0.22
    20-Day Moving Average 0.26
    10-Day Moving Average 0.26
    Average True Range 0.05
    RSI (14) 56.52
    ADX 53.01
    +DI 38.04
    -DI 11.49
    Chandelier Exit (Long, 3 ATRs) 0.37
    Chandelier Exit (Short, 3 ATRs) 0.34
    Upper Bollinger Bands 0.31
    Lower Bollinger Band 0.21
    Percent B (%b) 0.77
    BandWidth 39.86
    MACD Line 0.01
    MACD Signal Line 0.01
    MACD Histogram -0.0023
    Fundamentals Value
    Market Cap 6.48 Million
    Num Shares 22.3 Million
    EPS -2.44
    Price-to-Earnings (P/E) Ratio -0.12
    Price-to-Sales 1.61
    Price-to-Book 0.24
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.44
    Resistance 3 (R3) 0.44 0.38 0.42
    Resistance 2 (R2) 0.38 0.34 0.38 0.41
    Resistance 1 (R1) 0.34 0.32 0.36 0.34 0.40
    Pivot Point 0.28 0.28 0.29 0.28 0.28
    Support 1 (S1) 0.23 0.24 0.26 0.24 0.18
    Support 2 (S2) 0.18 0.22 0.18 0.17
    Support 3 (S3) 0.13 0.18 0.16
    Support 4 (S4) 0.14